Group B streptococci prophylaxis or clinically suspected intraamniotic infection as indicated
Primary study outcome
Interval from induction to delivery
Mode of delivery
Maternal and newborn outcomes
201 women were enrolled in the study
93 were allocated to Foley group
108 to oxytocin group
Time to delivery was not significantly different between groups (P=.69)
Foley group: 13.9 hours (±6.9 SD)
Oxytocin group: 14.4 hours (±7.9 SD)
There were more cases of clinical chorioamnionitis (8% compared with 0%, P<.01) in the Foley group compared with the oxytocin group
The introduction of Foley in addition to oxytocin did not shorten time between induction and delivery but did introduce risk for chorioamnionitis
Study used clinical assessment of infection and not placental pathology (1/3 of case underwent pathologic review)
However, authors state that the study was adequately powered to determine a difference in chorioamnionitis and the results of this study “should make us question whether use of a Foley catheter is appropriate in those with ruptured membranes”
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan